All times are listed in CEST (Central European Summer Time)

Displaying One Session

View
Industry Satellite Symposium

PeerView Oncology - Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients

Date
Fri, 09.09.2022
Time
10:15 - 11:45
Chairs
  • Aleix Prat (Barcelona, Spain)
Industry Satellite Symposium

Welcome and Introduction

Speakers
  • Aleix Prat (Barcelona, Spain)
Session Name
PeerView Oncology - Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients
Location
7.3.H - Honfleur Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Fri, 09.09.2022
Time
10:15 - 11:45
Industry Satellite Symposium

Understanding the Foundational Concepts of HER2-Low Breast Cancer: Challenges and Opportunities of an Evolving Definition

Speakers
  • Paolo Tarantino (Boston, United States of America)
Session Name
PeerView Oncology - Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients
Location
7.3.H - Honfleur Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Fri, 09.09.2022
Time
10:15 - 11:45
Industry Satellite Symposium

Extending Anti-HER2 Therapy Benefits to a Larger Population of Patients: Emerging Evidence, Implementation in Clinical Practice, and Future Directions

Speakers
  • Shanu Modi (New York, United States of America)
Session Name
PeerView Oncology - Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients
Location
7.3.H - Honfleur Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Fri, 09.09.2022
Time
10:15 - 11:45
Industry Satellite Symposium

Unveiling the Biology of HER2-Low Breast Cancer: Insights From Genomics, Transcriptomics, and Opportunities With Evolving Testing Approaches

Speakers
  • Aleix Prat (Barcelona, Spain)
Session Name
PeerView Oncology - Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients
Location
7.3.H - Honfleur Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Fri, 09.09.2022
Time
10:15 - 11:45
Industry Satellite Symposium

Exploring the Nuances of HER2-Targeted Treatment Selection for Patients With HER2-Low Breast Cancer: Expert Insights Into Implications for Practice and Team-Based Approaches to Individualizing Patient Care

Speakers
  • Aleix Prat (Barcelona, Spain)
  • Paolo Tarantino (Boston, United States of America)
  • Shanu Modi (New York, United States of America)
Session Name
PeerView Oncology - Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients
Location
7.3.H - Honfleur Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Fri, 09.09.2022
Time
10:15 - 11:45
Industry Satellite Symposium

Summary, Reflections, and Key Takeaways

Speakers
  • Aleix Prat (Barcelona, Spain)
Session Name
PeerView Oncology - Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients
Location
7.3.H - Honfleur Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Fri, 09.09.2022
Time
10:15 - 11:45